Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Embolization: Features

Interview
An Overview of New and Upcoming Embolics
04/25/2024

Justin Guan, MD
Cleveland Clinic, Cleveland, Ohio

Justin Guan, MD Cleveland Clinic, Cle...
At the 2024 SIR Meeting, interventional radiologist Justin J. Guan, MD, presented several sessions, including “An Overview of New and Upcoming Embolics.” VDM spoke with Dr. Guan about how these new embolics can improve patient outcomes.
At the 2024 SIR Meeting, interventional radiologist Justin J. Guan, MD, presented several sessions, including “An Overview of New and Upcoming Embolics.” VDM spoke with Dr. Guan about how these new embolics can improve patient outcomes.
At the 2024 SIR Meeting,...
04/25/2024
Vascular Disease Management
Dr. Maureen Kohi
ISET 2024
What's New in Uterine Artery Embolization for Fibroids and Adenomyosis; Patient Selection and Technique for Hemorrhoid Embolization
02/15/2024
In this video, Dr. Maureen Kohi discusses her ISET presentations on embolization for fibroids and andenomyosis and embolization techniques for hemorrhoid disease.
In this video, Dr. Maureen Kohi discusses her ISET presentations on embolization for fibroids and andenomyosis and embolization techniques for hemorrhoid disease.
In this video, Dr. Maureen Kohi...
02/15/2024
Vascular Disease Management
Review
Embolics Review: Current Options and Agents in the Pipeline
11/26/2023
This review aims to provide a brief overview of embolic agents currently available with a focus on new and upcoming options and their associated strengths and weaknesses.
This review aims to provide a brief overview of embolic agents currently available with a focus on new and upcoming options and their associated strengths and weaknesses.
This review aims to provide a...
11/26/2023
Vascular Disease Management
Case Report
Percutaneous Glue Embolization of Ectopic Varices in the Anterior Abdominal Wall of a Patient Who Presented With Nonhealing Discharging Sinus in the Right Iliac Fossa: Box-Assisted Retrograde Obliteration (BxRTO)
11/08/2023
An unusual presentation of ectopic varices.
An unusual presentation of ectopic varices.
An unusual presentation of...
11/08/2023
Vascular Disease Management
Interview
Early Outcomes and Safety of Prostate Embolization With n-Butyl Cyanoacrylate Liquid Embolic
06/19/2023
Dr. Bamshad presented results from a retrospective study that assessed the feasibility, safety, and short-term efficacy of n-Butyl cyanoacrylate (n-BCA) glue embolization for prostate artery embolization.
Dr. Bamshad presented results from a retrospective study that assessed the feasibility, safety, and short-term efficacy of n-Butyl cyanoacrylate (n-BCA) glue embolization for prostate artery embolization.
Dr. Bamshad presented results...
06/19/2023
Vascular Disease Management
Review
Geniculate Artery Embolization: A Review of Hemarthrosis and Osteoarthritis
05/17/2023
This review demonstrates support for the efficacy of geniculate artery embolism and describes the common techniques, with the goal to propagate its use where appropriate to give many patients a chance for improvement in symptoms.
This review demonstrates support for the efficacy of geniculate artery embolism and describes the common techniques, with the goal to propagate its use where appropriate to give many patients a chance for improvement in symptoms.
This review demonstrates support...
05/17/2023
Vascular Disease Management
Case Report with Review
Multidisciplinary Management of Cervical Ectopic Pregnancy: A Report of Two Cases
05/17/2023
Two cases are presented of patients who had minimal intraoperative blood loss secondary to IR placement of intra-arterial occlusion balloons prior to evacuation of cervical ectopic pregnancy.
Two cases are presented of patients who had minimal intraoperative blood loss secondary to IR placement of intra-arterial occlusion balloons prior to evacuation of cervical ectopic pregnancy.
Two cases are presented of...
05/17/2023
Vascular Disease Management
Case Report With Review
An Unusual Cause of Pelvic Congestion Syndrome
05/17/2023
In this case, the symptoms of PCS resulted secondary to venous obstruction. A variant form of May-Thurner syndrome was identified on contrast-enhanced CT, where the common trunk of the IIVs was compressed by the right common iliac artery.
In this case, the symptoms of PCS resulted secondary to venous obstruction. A variant form of May-Thurner syndrome was identified on contrast-enhanced CT, where the common trunk of the IIVs was compressed by the right common iliac artery.
In this case, the symptoms of...
05/17/2023
Vascular Disease Management
Interview
Genicular Artery Embolization in 2023: An Interview With Dr. Osman Ahmed
05/17/2023
VDM spoke with Dr. Ahmed to discuss the latest studies on GAE for OA of the knee and what their results mean for the future of this treatment.
VDM spoke with Dr. Ahmed to discuss the latest studies on GAE for OA of the knee and what their results mean for the future of this treatment.
VDM spoke with Dr. Ahmed to...
05/17/2023
Vascular Disease Management
Interview
Results of the GPX Embolic Device Clinical Trial: An Interview With Dr. Andrew Holden
04/20/2023
At the 2023 Society of Interventional Radiologists Annual Meeting in Phoenix, Arizona, Interventional Radiologist Andrew Holden, ONZM, MBChB, FRANZCR, EBIR, from Auckland City Hospital in New Zealand, presented final results from the GPX...
At the 2023 Society of Interventional Radiologists Annual Meeting in Phoenix, Arizona, Interventional Radiologist Andrew Holden, ONZM, MBChB, FRANZCR, EBIR, from Auckland City Hospital in New Zealand, presented final results from the GPX...
At the 2023 Society of...
04/20/2023
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement